Methodes et compositions de traitement de l'otite moyenne

Methods and compositions for treatment of otitis media

Abstract

The invention is directed to the treatment of otitis media by administration of protease inhibitors. In some embodiments, the protease inhibitors are alpha one-antitrypsin and/or ilomastat.
L'invention concerne le traitement de l'otite moyenne par administration d'inhibiteurs de protéase. Dans certains modes de réalisation, les inhibiteurs de protéase sont alpha one-antitrypsine et/ou ilomastat.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (2)

    Publication numberPublication dateAssigneeTitle
    US-5217951-AJune 08, 1993John Lezdey, Wachter Allan JTreatment of inflammation
    US-6174859-B1January 16, 2001J & D Sciences, Inc.Method of treatment

NO-Patent Citations (1)

    Title
    See also references of EP 1567183A2

Cited By (5)

    Publication numberPublication dateAssigneeTitle
    JP-2015083589-AApril 30, 2015フォーサイト・バイオセラピューティクス・インコーポレーテッド, Foresight Biotherapeutics IncOtic compositions useful for treatment of infections of internal and external ear in mammals
    JP-2017031202-AFebruary 09, 2017フォーサイト・バイオセラピューティクス・インコーポレーテッド, Foresight Biotherapeutics IncOtic compositions useful in treatment of infections of internal and external ear in mammals
    US-7678767-B2March 16, 2010Pneumrx, Inc.Glue compositions for lung volume reduction
    US-7766938-B2August 03, 2010Pneumrx, Inc.Pleural effusion treatment device, method and material
    US-RE46209-ENovember 22, 2016Pneumrx, Inc.Glue composition for lung volume reduction